-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

clonoSEQ and MRD Assessment in the Management of Lymphoid Malignancies

Program: Product Theaters
Session: clonoSEQ and MRD Assessment in the Management of Lymphoid Malignancies
Monday, December 7, 2020, 10:30 AM-11:30 AM

Lanny R. Kirsch, MD

Adaptive Biotechnologies, Seattle, WA

Disclosures: No relevant conflicts of interest to declare.

See more of: clonoSEQ and MRD Assessment in the Management of Lymphoid Malignancies
See more of: Product Theaters